Decision to list medical devices supplied by Medtronic New Zealand Limited

Decision

We are pleased to announce the approval of a listing agreement for the supply of medical devices to DHBs.

What we’re doing

We are pleased to announce the approval of the non-exclusive listing agreement with Medtronic New Zealand Limited (“Medtronic”) for the supply of:

This will result in 417 of Medtronic’s medical devices being listed in the categories above in Part III, of Section H, of the Pharmaceutical Schedule from 1 May 2021.

DHBs will be able to continue to purchase other suppliers’ brands of endomechanical and electrosurgical products and haemodialysis products as the agreement is not for sole supply.

Any changes to the original proposal?

This decision was subject to a consultation letter dated 4 March 2021.

There were no changes made to the Agreement as a result of the consultation feedback.

Who we think will be most interested

  • DHB Staff
    • Clinical engineers
    • Surgeons
    • Perioperative staff
    • Theatre staff
    • Procurement and supply chain personnel
    • Surgical and general ward staff
    • Central sterile services personnel
    • Renal Dialysis staff
  • Suppliers and wholesalers

Details about this decision

In 2018 PHARMAC issued a Request for Proposals (“RFPs”) for:

The RFPs requested proposals for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

Following evaluation of Medtronic’s responses to each RFP, and consultation on the provisional agreement reached, PHARMAC has decided to list Medtronic’s ranges of endomechanical and electrosurgical products, and haemodialysis products, in Part III of Section H of the Pharmaceutical Schedule from 1 May 2021.

The brands and number of products per category included in the Medtronic agreement are:

Category

Brands

Line items

Haemodialysis

  • Argyle
  • Mahurkar Elite
  • Palindrome

40

Endomechanical and Electrosurgical

  • AbsorbaTack
  • Appose
  • Aquamantys
  • Autosuture Locking Trocar
  • Blunt Tip
  • DST ranges
  • EEA Tri-Staple Technology
  • Endo ranges
  • Ligasure
  • Medtronic
  • Multifire ranges
  • Plasma Blade
  • Polysorb
  • Premium Plus CEEA
  • Protack
  • Purstring
  • ReliaCatch
  • ReliaTack
  • Roticulator Stapler
  • Signia
  • SILS
  • Sofsilk
  • Stat Tack
  • Surgidac
  • SurgiNeedle
  • SurgiSleeve
  • Surgitie
  • Surgiwand II
  • Thoracoport
  • Tri-Staple 2.0
  • Valleylab
  • VersaOne
  • Versaport
  • VersaStep Plus
  • Visiport Plus RPF
  • V-Loc

377

DHBs that purchase these categories of medical devices, from Medtronic, must do so under the terms and conditions, and at the prices included in the agreement from the listing date. DHBs can continue to choose which endomechanical and electrosurgical products, and haemodialysis products they purchase.

The agreement includes terms and conditions for training and education, to be provided by Medtronic, on the appropriate use of their products, which is to be provided at times as agreed with individual DHBs.

The list of products will be available on PHARMAC’s website from 1 May 2021, in both PDF and Excel spreadsheet formats.

Our response to what you told us

We appreciate the time people took to respond to this consultation.

All consultation responses received by noon 25 March 2021 were considered in their entirety in making the decision to approve this agreement.

A summary of the main themes raised in feedback and our responses to the feedback are set out below:

Theme

Comment

Supplier unit of measure clarifications sought

Verification sought and confirmed.

Clarification sought on supplier relationship arrangements outside the PHARMAC agreement.

While it is expected suppliers have ongoing relationships with their customers, the PHARMAC agreements cover all terms and conditions for the supply and purchase of medical devices listed and supersede all other arrangements.

No technical or resource impacts are expected as a result of the proposal.

Noted.

Support for the non-exclusivity of the agreement, also noting need for training and education on use of products would be required.

Noted.

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.